Chemical Consortium Holdings, Inc. Receives NASDAQ Share Reorganization Approval and New Symbol

Share Article

Chemical Consortium Holdings, Inc. (Pink Sheets: CCSH) announced today that the shareholder approved share reorganization completed July 30, 2005 was formally approved by the NASDAQ with an effective date of August 29, 2005.

Beginning on August 29, 2005, Chemical Consortium will trade under the symbol CCMH. The 10-1 share consolidation will be effective prior to trading. All necessary filings with the State of Delaware, the Pink Sheets and the NASDAQ have been made. Total shares outstanding following the consolidation will be 13,239,855. Please see the company Web site for further details of consolidation numbers at or contact the market integrity department of the NASDAQ.

Chemical Consortium Holdings, Inc. (ChemCon) is a holding company for alternative fuel manufacturing assets. ChemCon is currently developing a biodiesel and ethanol production facility in SW Washington State. The four stage facility will produce biodiesel and ethanol. Stage one is currently in engineering and is scheduled to begin Engineering Procurement Contracting (EPC) in November 2005. Construction of stage one is tentatively scheduled to begin in March of 2006. Stage one of the facility is slated to produce up to 30 million gallons of biodiesel annually.

Except for the historical information presented herein, the matters set forth in this press release are forward looking statements within the meaning of the "safe-harbor" provision of the Private Securities Litigation reform Act of 1995. These forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks are detailed in the Company's period reports filed with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. The Company disclaims any intent or obligation to update these forward-looking statements.

For more information, contact Benjamin Schoenung at 1-877-840-2053.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Benjamin Schoenung
Visit website